Swiss federal government reserves 2000 packs of a drug to treat COVID-19
15. Februar 2022 – The Swiss federal government has signed a contract with GlaxoSmithKline AG to reserve a promising medication called the Monoclonal Antibody Sotrovimab for treating COVID-19. This is the third contract of this type concluded with the company since the outbreak of the COVID-19 pandemic.
For more information, see here.